XHKG
8372
Market cap12mUSD
Dec 05, Last price
0.12HKD
1D
0.00%
1Q
0.85%
IPO
-64.24%
Name
Grand Brilliance Group Holdings Ltd
Chart & Performance
P/E
9.98
P/S
1.00
EPS
0.01
Div Yield, %
2.12%
Shrs. gr., 5y
—
Rev. gr., 5y
7.04%
Revenues
94m
+15.32%
Net income
9m
+20.43%
CFO
1m
-79.87%
Dividend
Jul 15, 20240.0025 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. It offers medical consumables; medical instruments; and medical equipment, as well as develops healthcare products. The company also provides medical device solutions, such as market trend analysis, sourcing of medical devices, after-sale services, technical support and training services, medical devices leasing services, and quality assurance services; and maintenance services, as well as holds trademarks. It sells its products to various private and public hospitals, private clinics, non-profit organizations, universities, and individual end-users. The company was founded in 1997 and is based in Tsuen Wan, Hong Kong. Grand Brilliance Group Holdings Limited is a subsidiary of B&A Success Limited.
IPO date
Mar 29, 2018
Employees
41
Domiciled in
HK
Incorporated in
KY
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||